Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadritherapy vs Triple Therapy vs Standard of Care for Naïve Chronic Hepatitis C Genotype 4
NCT01896609Phase 4Unknown
- Sponsor
- Minapharm Pharmaceuticals
- Start
- Jun 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitazoxanide, alfacalcidol in hepatitis C (HCV), sponsored by Minapharm Pharmaceuticals. Status: unknown.
02
Drugs
nitazoxanidealfacalcidol
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01896609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896609.